Bellevue Asset Management’s Avanos Medical AVNS Stock Holding History

Bellevue Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50	Closed	-$1.12K	–	458
2023 Q4	$1.12K	Hold	50	–	–	﹤0.01%	452
2023 Q3	$1.01K	Hold	50	–	–	﹤0.01%	448
2023 Q2	$1.28K	Hold	50	–	–	﹤0.01%	453
2023 Q1	$1.49K	Hold	50	–	–	﹤0.01%	454
2022 Q4	$1.35K	Hold	50	–	–	﹤0.01%	453
2022 Q3	$1K	Hold	50	–	–	﹤0.01%	458
2022 Q2	$1K	Hold	50	–	–	﹤0.01%	463
2022 Q1	$2K	Hold	50	–	–	﹤0.01%	438
2021 Q4	$2K	Hold	50	–	–	﹤0.01%	477
2021 Q3	$2K	Hold	50	–	–	﹤0.01%	502
2021 Q2	$2K	Hold	50	–	–	﹤0.01%	503
2021 Q1	$2K	Hold	50	–	–	﹤0.01%	553
2020 Q4	$2K	Hold	50	–	–	﹤0.01%	572
2020 Q3	$2K	Hold	50	–	–	﹤0.01%	528
2020 Q2	$1K	Hold	50	–	–	﹤0.01%	581
2020 Q1	$2K	Hold	50	–	–	﹤0.01%	491
2019 Q4	$2K	Buy	+50	New	+$1.81K	﹤0.01%	421

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Bellevue Asset Management's AVNS Position: Q1 2024 in Review

Bellevue Asset Management sold out of Avanos Medical (AVNS) in Q1 2024, closing a stake of 50 shares — an estimated $1.12K sold.

Bellevue Asset Management first reported a position in AVNS in Q4 2019 and held it in 17 quarters. The position peaked at $2K in Q1 2022. 261 funds tracked by Wall St. Rank hold AVNS as of Q1 2024.

Bellevue Asset Management reported no remaining Avanos Medical position as of Q1 2024 after selling out during the quarter.
Bellevue Asset Management sold 50 Avanos Medical shares in Q1 2024, an estimated $1.12K.
Bellevue Asset Management first reported a position in Avanos Medical in Q4 2019 and held it in 17 quarters.
Bellevue Asset Management's Avanos Medical position peaked at $2K in Q1 2022.
261 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2024.

Based on Bellevue Asset Management's 13F filing for Q1 2024, filed 26 Apr 2024.